1
|
Ueki D, Suzuki S, Ohta T, Shinohara A, Ohashi Y, Konuma D, Ryushima Y, Udagawa R, Motoshige H, Ieoka M, Taji A, Kogure Y, Hiraike M, Uoi M, Ino K, Kawasaki T, Yamaguchi M. Cancer-Chemotherapy-Related Regimen Checks Performed by Pharmacists of General Hospitals Other than Cancer Treatment Collaborative Base Hospitals: A Multicenter, Prospective Survey. PHARMACY 2023; 12:1. [PMID: 38392922 PMCID: PMC10891652 DOI: 10.3390/pharmacy12010001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2023] [Revised: 12/14/2023] [Accepted: 12/17/2023] [Indexed: 02/25/2024] Open
Abstract
Although prescription review is an important role for pharmacists in anticancer drug therapy, there are no guidelines in Japan that specify what pharmacists should check for in chemotherapy regimens. This prospective multicenter survey aimed to investigate the implementation of chemotherapy regimen checks by pharmacists in general hospitals by focusing on 19 recommended confirmation items designed to enhance chemotherapy safety. This study involved 14 hospitals within the National Hospital Organization in different regions of Japan. The top five cancers in Japan (gastric, colorectal, lung, breast, and gynecological) were targeted and specific chemotherapy regimens were analyzed. This study assessed the amount of time required for regimen checks, the number of confirmation items completed, the number and the content of inquiries raised regarding prescriptions, and the pharmacists' opinions using a questionnaire that had a maximum score of 10 points. Pharmacists checked 345 and 375 chemotherapies of patients in the control group (CG) and recommended items group (RIG), respectively. The mean time periods required for completing a chemotherapy regimen check were 4 min and 14 s (SD ±1 min and 50 s) and 6 min and 18 s (SD, ±1 min and 7 s) in the CG and RIG, respectively. The mean of the recommended items for the CG = 12.4 and for the RIG = 18.6. The items that the pharmacists did not confirm included urine protein (sixty-nine cases, 18.4%), allergy history (four cases, 1%), previous history (two cases, 0.5%), and a previous history of hepatitis B virus (sixty-nine cases, 18.4%). The number of inquiries for a doctor's prescription order was higher in the RIG than in the CG (41 vs. 27 cases). This multicenter survey demonstrated the potential effectiveness of implementing 19 recommended confirmation items in the regimen checks by pharmacists in general hospitals other than cancer treatment collaborative base hospitals.
Collapse
Affiliation(s)
- Daisuke Ueki
- Department of Pharmacy, National Hospital Organization Tokyo National Hospital, Tokyo 204-8585, Japan
| | - Shinya Suzuki
- Department of Pharmacy, National Cancer Center Hospital East, Chiba 277-8577, Japan
| | - Takahiro Ohta
- Department of Pharmacy, National Hospital Organization Tokyo Medical Center, Tokyo 152-8902, Japan
| | - Akira Shinohara
- Department of Pharmacy, National Cancer Center Hospital East, Chiba 277-8577, Japan
| | - Yasukata Ohashi
- Department of Pharmacy, National Center for Global Health and Medicine, Tokyo 162-8655, Japan
| | - Daisuke Konuma
- Department of Pharmacy, National Hospital Organization Chiba Medical Center, Chiba 260-8606, Japan
| | - Yasuaki Ryushima
- Department of Pharmacy, National Hospital Organization Saitama Hospital, Saitama 351-0102, Japan
| | - Ryoko Udagawa
- Department of Pharmacy, National Cancer Center Hospital, Tokyo 104-0045, Japan
| | - Hironori Motoshige
- Department of Pharmacy, National Hospital Organization Hokkaido Medical Center, 5-7 Yamanote, Nishi-ku, Sapporo 063-0005, Japan
| | - Masahiro Ieoka
- Department of Pharmacy, National Hospital Organization Hamada Medical Center, Matsue 697-8511, Japan
| | - Akihiro Taji
- Department of Pharmacy, National Hospital Organization Osaka Minami Medical Center, Osaka 586-8521, Japan
| | - Yuuki Kogure
- Department of Pharmacy, National Hospital Organization Higashihiroshima Medical Center, Hiroshima 739-0041, Japan
| | - Mikako Hiraike
- Department of Pharmacy, National Hospital Organization Kumamoto Medical Center, Kumamoto 860-0008, Japan
| | - Miyuki Uoi
- Department of Pharmacy, National Hospital Organization Kyusyu Cancer Center, Fukuoka 811-1395, Japan
| | - Kazuhiko Ino
- Department of Pharmacy, National Hospital Organization Tokyo National Hospital, Tokyo 204-8585, Japan
| | - Toshikatsu Kawasaki
- Department of Pharmacy, National Cancer Center Hospital East, Chiba 277-8577, Japan
| | - Masakazu Yamaguchi
- Department of Pharmacy, Cancer Institute Hospital, Tokyo 135-8550, Japan
| |
Collapse
|